DWA
ARVN icon

Dorsey Wright & Associates’s Arvinas ARVN Stock Holding History

Dorsey Wright & Associates’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-396
Closed -$16K – 315
2020
Q1 		$16K Sell
396
-37
-9% -$1.73K 0.01% 113
2019
Q4 		$18K Hold
433
– – 0.01% 132
2019
Q3 		$9K Buy
+433
New +$10.6K ﹤0.01% 269

Other funds holding ARVN

CPI
Canaan Partners IX Menlo Park, California $87.5M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dorsey Wright & Associates's ARVN Position: Q2 2020 in Review

Dorsey Wright & Associates sold out of Arvinas (ARVN) in Q2 2020, closing a stake of 396 shares — an estimated $16K sold.

Dorsey Wright & Associates first reported a position in ARVN in Q3 2019 and held it in 3 quarters. The position peaked at $18K in Q4 2019. 142 funds tracked by Wall St. Rank hold ARVN as of Q2 2020.

  • Dorsey Wright & Associates reported no remaining Arvinas position as of Q2 2020 after selling out during the quarter.
  • Dorsey Wright & Associates sold 396 Arvinas shares in Q2 2020, an estimated $16K.
  • Dorsey Wright & Associates first reported a position in Arvinas in Q3 2019 and held it in 3 quarters.
  • Dorsey Wright & Associates's Arvinas position peaked at $18K in Q4 2019.
  • 142 funds tracked by Wall St. Rank held Arvinas as of Q2 2020.

Based on Dorsey Wright & Associates's 13F filing for Q2 2020, filed 23 Jul 2020.